Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Leukocyte-reduced blood products

J G Kadar1

  • 1Department of Transfusion Medicine, Hannover Medical School, Germany.

Current Opinion in Hematology
|November 14, 1998
PubMed
Summary

Reducing leukocytes in blood transfusions is crucial for patient safety, especially for those undergoing chemotherapy. Current methods like filtration and centrifugation show promise, but optimal strategies for leukocyte reduction remain under investigation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IgE-mediated anaphylactic reaction to purified and recombinant factor VIII in a patient with severe haemophilia A.

Haemophilia : the official journal of the World Federation of Hemophilia·2007
Same author

[Quality of washed autologous erythrocytes from drainage-suction pumps].

Anaesthesiologie und Reanimation·1999
Same author

Therapeutic immunoadsorption--its role in clinical practice.

Transfusion science·1998
Same author

Immunological effects of therapeutic immunoadsorption with respect to biocompatibility.

Transfusion science·1998
Same author

Imprecision of counting CFU-GM colonies and CD34-expressing cells.

Bone marrow transplantation·1997
Same author

Simultaneous genotyping of human platelet antigens by hot start sequence-specific polymerase chain reaction with DNA polymerase AmpliTaq Gold.

Vox sanguinis·1997

Area of Science:

  • Transfusion Medicine
  • Immunology

Background:

  • Advances in blood component preparation are driven by the need for safer transfusions.
  • Concerns exist regarding immunological effects of transfused leukocytes and their impact on patients, particularly those with malignant diseases undergoing intensive chemotherapy.

Purpose of the Study:

  • To review recent investigations on the effects of allogeneic leukocytes in blood transfusions.
  • To examine the comparative merits of different leukocyte reduction strategies.

Main Methods:

  • Review of recent journal articles focusing on leukocyte reduction in blood components.
  • Analysis of studies comparing filtration (secondary elimination) versus centrifugation (primary avoidance) of leukocytes.

Main Results:

  • Evidence highlights the immunological consequences of transfusing non-manipulated blood components.
  • The relative effectiveness of pre-storage versus post-storage filtration and specialized apheresis methods for leukocyte reduction is not yet clearly defined.

Conclusions:

  • Minimizing leukocyte content in allogeneic blood transfusions is a key objective.
  • Further research is needed to establish universal guidelines for the use of leukocyte-reduced blood components.

Related Experiment Videos